Correlation Between BIONTECH and Pfizer

Can any of the company-specific risk be diversified away by investing in both BIONTECH and Pfizer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BIONTECH and Pfizer into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BIONTECH SE DRN and Pfizer Inc, you can compare the effects of market volatilities on BIONTECH and Pfizer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BIONTECH with a short position of Pfizer. Check out your portfolio center. Please also check ongoing floating volatility patterns of BIONTECH and Pfizer.

Diversification Opportunities for BIONTECH and Pfizer

0.0

Correlation Coefficient

BIONTECH  Pfizer

Pay attention - limited upside

The 3 months correlation between BIONTECH and Pfizer is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding BIONTECH SE DRN and Pfizer Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pfizer Inc and BIONTECH is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BIONTECH SE DRN are associated (or correlated) with Pfizer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pfizer Inc has no effect on the direction of BIONTECH i.e., BIONTECH and Pfizer go up and down completely randomly.

Pair Corralation between BIONTECH and Pfizer

If you would invest  4,130  in BIONTECH SE DRN on October 7, 2024 and sell it today you would earn a total of  291.00  from holding BIONTECH SE DRN or generate 7.05% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	1.67%
Values	Daily Returns

BIONTECH SE DRN  vs.  Pfizer Inc

BIONTECH SE DRN

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in BIONTECH SE DRN are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, BIONTECH may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pfizer Inc

Risk-Adjusted Performance

0 of 100

Insignificant

Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong forward indicators, Pfizer is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with BIONTECH and Pfizer

The main advantage of trading using opposite BIONTECH and Pfizer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BIONTECH position performs unexpectedly, Pfizer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will offset losses from the drop in Pfizer's long position.

The idea behind BIONTECH SE DRN and Pfizer Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.